Biomarkers are important parameters that are reliable, applicable, reproducible and typically low-cost. They play a significant role in human health, particularly mechanistic biomarkers, which are of the utmost importance for preventing toxic effects and diseases. They can reflect the diagnosis, prognosis, recurrence and progression of diseases. Furthermore, they can indicate the level of human exposure to various chemical, biological and physical factors. Until now, developing and applying biomarkers has required an understanding of the underlying mechanisms involved in their production.

Biomarkers of environmental toxins can be used to measure exposure and effects, and some can be used to assess disease risk and susceptibility among individuals. Metabolites, proteins and DNA adducts can also help to elucidate the mechanisms of bioactivation and detoxification of toxic intermediates. Certain environmental chemicals act as modulators of gene and protein activity, inducing microbiome dysbiosis and affecting the metabolome and overall health.

To support these needs and accelerate scientific research, Creative Diagnostics now offers a range of monoclonal and polyclonal antibodies for environmental toxicology biomarker research. The portfolio covers key targets associated with exposure and effects, such as CYP1A, vitellogenin (Vtg), metallothionein (MT) and zonulin (Zrp). They can react with common research fish, including rainbow trout, Atlantic salmon, Atlantic cod, carp, flounder, zebrafish, bluegill, killifish and three-spined stickleback, as well as specific wildlife models such as alligators and birds.

For example, Creative Diagnostics now offers the Mouse anti-fish CYP1A peptide Monoclonal antibody (Catalog # CABT-L1857W) for ELISA and WB applications. This antibody can cross-react with CYP1A in liver samples from various fish species, including rainbow trout (Oncorhynchus mykiss), Atlantic salmon (Salmo salar), carp (Cyprinus carpio), halibut (Scophthalmus maximus) and Atlantic cod (Gadus morhua). The extent of cross-reactivity varies depending on the species and the method used. This product has performed well in ELISA and Western blot experiments across multiple species, as well as in immunohistochemical experiments. As detection conditions vary, the optimal dilution ratio must be determined for each application.

Creative Diagnostics' environmental toxicology biomarker antibodies can support researchers in assay development, biomarker monitoring, comparative biology, ecotoxicological testing, and contaminant impact assessments. For detailed product specifications, species cross-reactivity data, or to explore the complete catalog, please visit https://www.creative-diagnostics.com/environmental-toxicology-biomarker-antibodies.htm.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing needs.

This article mainly introduces the in vitro antibody activity test service of creative diagnostics.

Creative Diagnostics offers Kinase Activity Assay with near-infrared microarray protein chip technology for drug development and safety analysis.

The Kinase Activity Assay is a biochemical detection method of kinase activity (the enzymes that move phosphate molecules from ATP to a substrate (usually protein). The process - known as phosphorylation - governs a range of cell functions, such as signal transduction, cell growth and differentiation. Kinases are also implicated in a variety of pathologies, and are therefore prime candidates for drug discovery and production. Accurate measurement of kinase function is crucial for cell signaling mechanisms and drug discovery for diseases mediated by kinases, especially cancers.